The data prompt the question as to whether Gdf8/ActRIIB ligand signaling is a key central mechanism by which the liver communicates with muscle more broadly in hepatic injury and disease, including NASH and cirrhosis. This evidence concerns the gene ACVR2B and metabolic dysfunction-associated steatohepatitis.